REQUEST A DEMO
Total
USD $0.00
Search more companies

Centro Terapeutico Re-Encontrarse S.A.S. (Colombia)

Main Activities: General Medical and Surgical Hospitals
Full name: Centro Terapeutico Re-Encontrarse S.A.S. Profile Updated: May 29, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Centro Terapeutico Re-Encontrarse S.A.S. is based in Colombia. The head office is in Barranquilla. It operates in the General Medical and Surgical Hospitals industry. The company was established on May 20, 2011. It currently has a total number of 48 (2023) employees. In its most recent financial highlights, the company reported a net sales revenue increase of 39.37% in 2023. Its total assets grew by 52.27% over the same period. The net profit margin of Centro Terapeutico Re-Encontrarse S.A.S. increased by 22.49% in 2023.

Headquarters
Cr 45 No 84 - 197
Barranquilla; Atlantico;

Contact Details: Purchase the Centro Terapeutico Re-Encontrarse S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Centro Terapeutico Re-Encontrarse S.A.S. report to view the information.
Outstanding Shares:
Purchase the Centro Terapeutico Re-Encontrarse S.A.S. report to view the information.
Incorporation Date:
May 20, 2011
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Purchase this report to view the information.
Fiscal Inspector
Purchase this report to view the information.
Alternate Fiscal Auditor
Company Performance
Financial values in the chart are available after Centro Terapeutico Re-Encontrarse S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
39.37%
Total operating revenue
39.37%
Operating profit (EBIT)
242.83%
EBITDA
236.91%
Net Profit (Loss) for the Period
295.71%
Total assets
52.27%
Total equity
103.04%
Operating Profit Margin (ROS)
24%
Net Profit Margin
22.49%
Return on Equity (ROE)
23.31%
Quick Ratio
0.6%
Cash Ratio
0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?